New Research Identifies Critical Gaps in Mental Health Care for Adults With Schizophrenia Spectrum Disorders Sep. 23, 2024 — New research finds that adults with schizophrenia spectrum disorders ...

The Brain & Behavior Research Foundation (BBRF) has announced the 2024 Leading Research Achievements by BBRF grantees, prizewinners, and scientific council members. It includes important studies of ...

Alcohol use can worsen symptoms of depression, mania, or hypomania in bipolar disorder and may have other negative effects on ...

It is a myth that people with mental health conditions cannot do school work, office work or daily tasks. Support and therapy ...

Brilaroxazine hydrochloride is under clinical development by Reviva Pharmaceuticals and currently in Phase I for Major Depressive Disorder.

Pitolisant hydrochloride is under clinical development by Bioprojet SCR and currently in Phase II for Autism Spectrum Disorder (ASD).

Lithium, a drug commonly used to treat bipolar disorder and depression, has emerged as a potential therapy for autism ...

Lithium, a drug widely used for bipolar disorder, may also treat autism spectrum disorder (ASD), according to new research.

Such extreme mood swings are often misinterpreted as bipolar disorder. However, mood swings in BPD typically have a clear trigger and last a few hours. Mood swings in people living with bipolar ...

A groundbreaking discovery has highlighted lithium-;a drug long used to treat bipolar disorder and depression-;as a potential therapy for autism spectrum disorder (ASD).

A discovery has highlighted lithium—a drug long used to treat bipolar disorder and depression—as a potential therapy for autism spectrum disorder (ASD). This research, conducted by a team at ...

In schizoaffective disorder, bipolar type, individuals have both bipolar symptoms and distinct psychotic episodes. Since psychosis is a common symptom in bipolar disorder, the right diagnosis can be ...